TKI Monotherapy Still has a Role in mRCC Front-Line Therapy

Bradley A McGregor, MD Clinical Director Lank Center for Genitourinary Oncology Dana Farber Cancer Institute discusses TKI Monotherapy Still has a Role in mRCC Front-Line Therapy at the 2017 Kidney Cancer Association symposium in Miami, FL.